title: Linezolid resistant Staphylococcus haemolyticus: first case report from India.
abstract: Linezolid is being increasingly used in the treatment of infections with gram-positive organisms especially methicillin resistant Staphylococcal isolates. Though resistance to this antimicrobial is emerging but it is extremely rare. Here we document first case of linezolid resistant Staphylococcus haemolyticus (S.haemolyticus) from India. This organism was isolated from pus oozing from a postsurgical site in 61 year old male hailing from an adjoining state of Haryana.
authors.affiliation: Department of Microbiology, Government Medical College Hospital, Chandigarh, India. varshagupta_99@yahoo.com
authors.forename: Varsha
authors.initials: V
authors.lastname: Gupta
authors.forename: Shivani
authors.initials: S
authors.lastname: Garg
authors.forename: Ruby
authors.initials: R
authors.lastname: Jain
authors.forename: Sudhir
authors.initials: S
authors.lastname: Garg
authors.forename: Jagdish
authors.initials: J
authors.lastname: Chander
mesh_terms: D000081:Acetamides / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002981:Clindamycin / Q000494:pharmacology; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D006620:Hip Fractures / Q000150:complications / Q000382:microbiology* / Q000601:surgery; D006801:Humans; D007194:India; D000069349:Linezolid; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D023303:Oxazolidinones / Q000494:pharmacology*; D012293:Rifampin / Q000494:pharmacology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D041162:Staphylococcus haemolyticus / Q000187:drug effects* / Q000302:isolation & purification; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000382:microbiology*; D016896:Treatment Outcome
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D002981:Clindamycin; D000069349:Linezolid; D012293:Rifampin